Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.79%
1,091.93
-8.64
-0.79%
—1,100.571,098.941,103.801,084.24——
SIXC
Communications
SIXC
Communications
SIXC
-0.06%
604.79
-0.36
-0.06%
—605.15605.15606.69602.76——
SIXE
Energy
SIXE
Energy
SIXE
+1.51%
1,213.29
+18.10
+1.51%
—1,195.191,204.711,221.691,204.71——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.89%
1,724.40
-15.51
-0.89%
—1,739.911,734.501,734.501,710.67——
SIXM
Financials
SIXM
Financials
SIXM
+0.11%
639.28
+0.72
+0.11%
—638.56640.21645.32639.07——
SIXR
Staples
SIXR
Staples
SIXR
+0.61%
836.63
+5.06
+0.61%
—831.57840.48844.16834.54——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.67%
214.80
+1.44
+0.67%
—213.36213.36215.54212.77——
SIXT
Technology
SIXT
Technology
SIXT
-1.35%
3,190.37
-43.81
-1.35%
—3,234.183,171.863,195.363,145.46——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.02%
935.87
+0.22
+0.02%
—935.65937.31941.44933.16——
SIXV
Health care
SIXV
Health care
SIXV
+0.05%
1,450.04
+0.78
+0.05%
—1,449.261,454.771,462.651,447.95——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.62%
2,367.59
-14.86
-0.62%
—2,382.452,371.192,380.452,364.46——
AUROPHARMA:NSE
Aurobindo Pharma Ltd
₹1,425.00
+0.59%
(+8.30) 1D
Apr 28, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for AUROPHARMA...
Open
₹1,415.00
High
₹1,430.00
Low
₹1,410.30
Mkt. cap
825.42B
Avg. vol.
1.40M
Volume
847.63K
Dividend
0.28%
Quarterly dividend
₹1.00
Ex dividend date
Aug 8, 2025
P/E ratio
23.73
52-wk high
₹1,459.50
52-wk low
₹1,016.10
EPS
₹60.04
Shares outstanding
585.90M
No. of employees
28K
News stories
From sources across the web
Profile
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company based in HITEC City, Hyderabad, with U.S. headquarters in East Windsor, Mercer County, New Jersey. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include Pfizer and AstraZeneca. Wikipedia
About Aurobindo Pharma Ltd
CEO-
Employees27.7K
Founded1986
HeadquartersHyderabad, Andhra Pradesh, India
SectorPharmaceutical industry
Websiteaurobindo.com
Last report
Feb 9, 2026
Fiscal Period
Q3 2026
Normalized EPS / Estimate
16.43/ (15.89 est.)INR
+3.46%beat
Revenue / Estimate
86.46B/ (84.80B est.)INR
+1.95%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
83.82B
78.68B
82.86B
86.46B
Cost of goods sold
38.86B
32.39B
33.39B
34.81B
Cost of revenue
38.86B
32.39B
33.39B
34.81B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.34B
12.29B
12.77B
13.10B
Operating expense
30.73B
34.31B
36.98B
38.56B
Total operating expenses
69.58B
66.70B
70.37B
73.37B
Operating income
14.24B
11.98B
12.49B
13.09B
Other non operating income
-3.02B
1.05B
1.16B
1.54B
EBT including unusual items
13.35B
12.07B
12.76B
13.39B
EBT excluding unusual items
13.59B
12.07B
12.76B
14.04B
Income tax expense
4.32B
3.83B
4.28B
4.29B
Effective tax rate
32.38%
31.70%
33.53%
32.03%
Other operating expenses
14.53B
17.97B
19.91B
20.81B
Net income
9.03B
8.25B
8.48B
9.10B
Net profit margin
10.78%
10.48%
10.24%
10.53%
Earnings per share
15.56
14.20
14.61
16.43
Interest and investment income
3.56B
-
-
-
Interest expense
-981.70M
-977.50M
-952.40M
-927.70M
Net interest expenses
2.58B
-977.50M
-952.40M
-927.70M
Depreciation and amortization charges
3.86B
4.06B
4.29B
4.65B
EBITDA
17.86B
16.10B
16.66B
16.71B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer